Latest News about LLY
Recent news which mentions LLY
Pharmaceutical Giants Brace for Showdown as Medicare Drug Price Negotiations Are Poised For 2024
December 28, 2023
From Benzinga
Interested in the Weight-Loss Market? Here's 1 Stock to Buy Hand Over Fist in 2024, and 1 to Avoid Like the Plague.
December 28, 2023
From Motley Fool
Eli Lilly, Johnson & Johnson And Other Health Care Stocks From Wall Street's Most Accurate Analysts
December 28, 2023
From Benzinga
Recent M&A Bodes Well For Targeted Cancer Therapy Player Fusion Pharmaceuticals, Analyst Say AstraZeneca Is Favorably Positioned
December 27, 2023
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
December 27, 2023
From Benzinga
Bristol-Myers' Acquisition Of Karuna Therapeutics Paves Way For Aggressive Global Marketing Of KarXT: Analyst
December 26, 2023
From Benzinga
Structure Therapeutics Stock Just Crashed. Here's Why It Could Be Worth Buying Now
December 25, 2023
From Motley Fool
7 Small-Cap Stocks That Wall Street Loves for Good Reason
December 22, 2023
From InvestorPlace
Can This Red-Hot Stock Beat the Market Again in 2024?
December 22, 2023
Tickers
LLY
From Motley Fool
Looking Beyond Tech: 7 High-Growth Stocks for Substantial Returns
December 22, 2023
From InvestorPlace
These 3 Big Pharma Stocks Are Making Big Plays With AI
December 22, 2023
From Motley Fool
Weighing Their Chances: 5 Leading Healthcare Companies Fight for Market Share in the $100 Billion Weight-Loss Industry
December 21, 2023
From Motley Fool
Weight Loss Drugs By Novo Nordisk, Eli Lilly Don't Deter Nestle's Coffee Demand - CEO Explains Why
December 20, 2023
From Benzinga
COVAX Global Initiative For COVID-19 Vaccines Comes To An End Amid Shift To Regular Programs
December 20, 2023
From Benzinga
2 Unstoppable Growth Stocks to Buy in 2024
December 20, 2023
From Motley Fool
These 2 Unstoppable Stocks Could Make You Richer in 2024 and Beyond
December 20, 2023
From Motley Fool
3 Top Dividend Stocks That Recently Hiked Their Payouts
December 20, 2023
From Motley Fool
Goldman Sachs: Eli Lilly's Shares May Surge By 140% With GLP-1 Drug Boom
December 19, 2023
Tickers
LLY
From Benzinga
Obesity/Diabetes Drug Class GLP-1s' Cost-Saving Potential: Decoding Impact on Healthcare Spending
December 18, 2023
From Benzinga
These Are the 3 Hottest Biopharma Trends of 2024. Should You Invest?
December 18, 2023
From Motley Fool
As 2023 Comes To A Close And Updates Are Expected From Many Companies, Are These Three Unique Biotech Names On Your Watchlist?
December 18, 2023
From Benzinga
Are November’s 3 Biggest Stock Losers Worth Snapping Up Now?
December 17, 2023
From InvestorPlace
Patients Regain Weight After They Quit Using Ozempic Rival Zepbound. Here's Why That Makes Eli Lilly Stock an Even Better Buy.
December 16, 2023
From Motley Fool
3 Stocks Wall Street Bulls Are Betting On Big-Time
December 15, 2023
From InvestorPlace
The New Magnificent 7: 7 Stocks Rising to Prominence
December 15, 2023
From InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.